As part of the ESTRO scientific program, 16 presentations and posters detailing clinical use and experience with the MRIdian system were delivered, representing a 60 percent increase from the previous year's ESTRO meeting. Additional presentations focusing on clinical experience with MRIdian MR image-guided radiotherapy were delivered within the ViewRay booth. Videos of the in-booth talks are available at http://www.viewray.com/mr-image-guided-rt-webinar-conference-presentation-videos.
ViewRay's C2T2 comprises more than 20 leading institutions from around the world. Member institutions in attendance in Barcelona included VU University Medical Center (Amsterdam, Netherlands); Policlinico Agostino Gemelli (Rome, Italy); University Clinic Heidelberg (Heidelberg, Germany); Washington University and Siteman Cancer Center at Barnes-Jewish Hospital (St. Louis, Missouri); University of California, Los Angeles Health System (Los Angeles, California); University of Wisconsin (Madison, Wisconsin); University Hospital Zurich (Zurich, Switzerland); Herlev Hospital (Herlev, Denmark); Ludwig-Maximilians-University (Munich, Germany); National Cancer Center (Tokyo, Japan); Rigshospitalet (Copenhagen, Denmark); Institut Paoli Calmettes (Marseille, France); Seoul National University Hospital (Seoul, South Korea); Acibadem Maslak Hospital (Istanbul, Turkey); and Assuta Medical Center (Tel Aviv, Israel).
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Other C2T2 member institutions include Henry Ford Cancer Institute (Detroit, Michigan); Institut du Cancer de Montpellier (Montpellier, France); Loyola Center for Cancer Care and Research (Orland Park, Illinois); Moffitt Cancer Center (Tampa, Florida); Miami Cancer Institute at Baptist Health South Florida (Miami, Florida); New York-Presbyterian Hospital (New York, New York); Orlando Health UF Health Cancer Center (Orlando, Florida); and University of Miami Health System (Miami, Florida).
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges including beam distortion, skin toxicity, and other safety concerns, which may potentially occur when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
SOURCE ViewRay, Inc.
Back to HCB News
